tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Xylem price target raised to $168 from $164 at UBS

UBS raised the firm’s price target on Xylem (XYL) to $168 from $164 and keeps a Buy rating on the shares. Xylem’s Q2 results indicate the company is still flowing through relatively smooth waters, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1